Literature DB >> 32418325

Surface-enhanced Raman scattering analysis of serum albumin via adsorption-exfoliation on hydroxyapatite nanoparticles for noninvasive cancers screening.

Siqi Gao1, Mengmeng Zheng1, Yamin Lin1, Kecan Lin2, Jinshu Zeng2, Shusen Xie1, Yun Yu3, Juqiang Lin1.   

Abstract

Combining serum albumin via adsorption-exfoliation on hydroxyapatite particles (HAp) with surface-enhanced Raman scattering (SERS), we developed a novel quantitative analysis of albumin method from blood serum for cancers screening applications. The quantitatively analysis obtained by our HAp method had a good linear relationship from 1 to 10 g/dL, and the lower limit of detection was less than the albumin prognostic factor for disease (3.5 g/dL). Serum albumin was adsorbed and exfoliated by HAp from serum samples of liver cancer patients, breast cancer patients and healthy volunteers and mixed with silver colloids to perform SERS spectral analysis. Based on the PLS-SVM algorithm, the diagnostic accuracies of liver cancer patients and breast cancer patients were 100% and 96.68%, respectively. Moreover, this algorithm successfully predicted the unidentified subjects with a diagnostic accuracy of 93.75%. This exploratory work demonstrated that HAp-adsorbed-exfoliated serum proteins combined with SERS spectroscopy has great potential for cancer screening.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  adsorption-exfoliation; breast cancer; hydroxyapatite; liver cancer; serum albumin; surface-enhanced Raman scattering

Mesh:

Substances:

Year:  2020        PMID: 32418325     DOI: 10.1002/jbio.202000087

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  2 in total

Review 1.  Raman spectroscopy: current applications in breast cancer diagnosis, challenges and future prospects.

Authors:  Katie Hanna; Emma Krzoska; Abeer M Shaaban; David Muirhead; Rasha Abu-Eid; Valerie Speirs
Journal:  Br J Cancer       Date:  2021-12-10       Impact factor: 9.075

2.  Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma.

Authors:  Zhouyu Ning; Yingke Zhao; Xia Yan; Yongqiang Hua; Zhiqiang Meng
Journal:  Nanomaterials (Basel)       Date:  2022-06-15       Impact factor: 5.719

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.